Ladenburg Thalmann Financial Services’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-67
Closed -$1K 5448
2019
Q1
$1K Hold
67
﹤0.01% 5132
2018
Q4
$1K Hold
67
﹤0.01% 5112
2018
Q3
$1K Hold
67
﹤0.01% 5058
2018
Q2
$1K Hold
67
﹤0.01% 5033
2018
Q1
$1K Hold
67
﹤0.01% 5033
2017
Q4
$1K Hold
67
﹤0.01% 4945
2017
Q3
$1K Hold
67
﹤0.01% 4845
2017
Q2
$1K Hold
67
﹤0.01% 4786
2017
Q1
$1K Hold
67
﹤0.01% 4759
2016
Q4
$1K Buy
+67
New +$1.23K ﹤0.01% 4728
2016
Q1
Sell
-5
Closed 4830
2015
Q4
$0 Buy
+5
New +$217 ﹤0.01% 4809

Other funds holding ALIM

Ladenburg Thalmann Financial Services's ALIM Position: Q2 2019 in Review

Ladenburg Thalmann Financial Services sold out of Alimera Sciences (ALIM) in Q2 2019, closing a stake of 67 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in ALIM in Q4 2015 and held it in 11 quarters. The position peaked at $1K in Q1 2019. 41 funds tracked by Wall St. Rank hold ALIM as of Q2 2019.

  • Ladenburg Thalmann Financial Services reported no remaining Alimera Sciences position as of Q2 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 67 Alimera Sciences shares in Q2 2019, an estimated $1K.
  • Ladenburg Thalmann Financial Services first reported a position in Alimera Sciences in Q4 2015 and held it in 11 quarters.
  • Ladenburg Thalmann Financial Services's Alimera Sciences position peaked at $1K in Q1 2019.
  • 41 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2019, filed 15 Aug 2019.